Valion Bio VBIO Balance Sheet (2021-2026)

NASDAQ VBIO
$2.20 -0.20 (-8.33%)
At close: Sep 10, 2026 · 4:00 PM EDT
Reported Financials

Valion Bio Quarterly Balance Sheet

Periods 21 quarters
Latest Jun 2026

Valion Bio reported total assets of $32.47M and total liabilities of $20.59M for the quarter ended Jun 2026, up 759.8% year over year. This balance sheet covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
12.97M10.80M9.05M6.33M3.52M5.20M2.70M5.20M3.40M1.70M3.70M2.20M2.00M0.70M1.18M3.50M12.64M2.20M
Cash & Current Investments
12.97M10.80M9.05M6.33M3.52M5.20M2.70M5.20M3.40M1.70M3.70M2.20M2.00M0.70M1.18M3.50M12.64M2.20M
Receivables - NetNet Receivables
0.09M0.12M0.09M0.10M0.11M0.06M0.01M0.13M0.17M0.07M0.02M0.01M0.07M0.01M0.01M0.02M
Receivables
0.09M0.12M0.09M0.10M0.11M0.06M0.01M0.13M0.17M0.07M0.02M0.01M0.07M0.01M0.01M0.02M
Inventory
0.43M0.45M0.83M0.76M0.86M0.94M0.99M0.93M0.79M0.80M0.81M0.73M0.66M0.64M0.62M0.57M0.19M0.75M
Prepaid Assets
0.79M0.63M0.40M0.33M0.23M0.29M0.28M0.23M0.33M0.25M0.19M0.23M0.24M0.27M0.36M0.27M0.35M0.52M
Current Assets
14.29M12.00M10.37M7.59M5.31M6.48M4.00M6.46M4.65M2.83M4.66M3.16M2.64M1.26M1.84M3.74M13.01M3.38M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.01M0.02M0.01M0.01M0.01M0.10M0.12M0.12M0.12M0.12M0.12M0.12M0.00M0.12M0.12M0.01M12.64M12.34M
Goodwill
3.46M3.46M
Intangibles
2.24M2.24M2.24M
Goodwill & Intangibles
2.24M5.70M5.70M
Other Non-Current Assets
0.05M0.03M0.03M0.08M0.58M0.03M0.07M0.03M0.03M0.06M0.11M0.40M0.00M0.21M0.14M0.63M
Non-Current Assets
0.75M0.70M0.65M0.61M0.57M0.62M0.60M0.55M0.51M0.46M0.12M0.23M0.17M2.52M2.67M2.49M18.60M29.09M
Assets
15.04M12.69M11.03M8.21M5.88M7.10M4.60M7.01M5.16M3.29M4.78M3.39M2.81M3.78M4.51M6.23M31.61M32.47M
Liabilities
Current Liabilities
Accounts Payables
0.79M0.62M1.92M1.60M1.32M1.09M0.83M0.64M0.71M0.55M0.45M0.33M0.12M0.44M0.23M0.47M0.26M0.64M
Payables
0.79M0.62M1.92M1.60M1.32M1.09M0.83M0.64M0.71M0.55M0.45M0.33M0.12M0.44M0.23M0.47M0.26M0.64M
Accumulated Expenses
0.21M0.14M0.22M0.10M0.07M0.04M0.19M
Other Accumulated Expenses
0.27M0.30M0.29M0.26M0.39M0.30M0.14M0.19M0.49M0.27M0.14M0.23M0.13M0.30M0.59M0.17M0.38M1.83M
Current Leases
0.16M0.17M0.17M0.16M0.16M0.18M0.18M0.17M0.19M0.18M0.53M
Current Taxes
0.16M0.02M0.05M0.06M0.07M
Total Current Liabilities
1.22M1.10M2.38M2.02M1.88M1.57M1.16M1.00M1.40M0.99M0.59M0.56M0.27M0.74M0.82M0.64M0.65M3.05M
Non-Current Liabilities
Non-Current Debt
0.45M
Convertible Debt
6.45M7.39M
Non-Current Deffered Revenue
0.11M0.05M0.17M0.30M
Preferred Stock Liabilities
0.37M2.18M6.00M6.22M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.01M0.01M0.04M
Operating Leases
0.55M0.50M0.46M0.57M0.37M0.51M0.46M0.41M0.18M0.32M10.02M
Other Non-Current Liabilities
0.29M0.45M
Total Non-Current Liabilities
0.27M7.15M20.13M
Total Liabilities
3.60M5.79M1.76M1.60M2.84M2.44M2.25M1.90M1.44M1.24M1.58M1.13M0.59M0.56M0.27M0.74M0.82M0.64M7.44M20.59M
Shareholder's Equity
Total Debt
0.45M
Common Equity
-3.60M-5.79M13.27M11.09M8.19M5.77M3.63M5.21M3.16M5.76M3.58M2.15M4.19M2.83M2.54M3.04M3.69M3.41M16.80M4.25M
Liabilities and Shareholders Equity
15.04M12.69M11.03M8.21M5.88M7.10M4.60M7.01M5.16M3.29M4.78M3.39M2.81M3.78M4.51M6.23M31.61M32.47M
Retained Earnings
32.82M32.88M32.99M33.16M33.27M36.96M37.04M41.41M41.47M41.52M44.82M44.90M46.08M48.08M50.29M53.03M69.39M70.75M
Treasury Shares
0.01M0.01M